Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia

Explore clinical trials studying Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia trial results

Completed

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

NCT01209130

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Stanford, California, United States
  • Denver, Colorado, United States
  • Washington D.C., District of Columbia, United States
  • Boston, Massachusetts, United States
View Trial Details

Related conditions